CIK 0002029039 · Non-accelerated filer<br>Emerging growth company
Nasus Pharma Ltd
Sign in to watch- Ticker
- NSRX
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- other
- EIN
- 516022712
- Phone
- 972 54-255-3956
- Business address
- 29 HARAKEVET ST, TEL AVIV - YAFO, Israel, 6618003
- 424B5 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 424B4 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- UPLOAD Other SEC-generated Letter
- UPLOAD Other SEC-generated Letter
- UPLOAD Other SEC-generated Letter
- UPLOAD Other SEC-generated Letter
- UPLOAD Other SEC-generated Letter
- UPLOAD Other SEC-generated Letter
- UPLOAD Other SEC-generated Letter
Page 1 of 1 · 17 filings